My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Biogen Idec (NQ:BIIB)

181.06 +0.31 (+0.17%)

Streaming Delayed Price Updated: 3:08 PM EST, Dec 4, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Biogen Idec

< Previous 1 2

...

30 31 32 33 34 35 36 37 38

...

56 57 Next >

Is Seagen Stock a Buy Now? ↗

October 12, 2022

It's growing faster than competitors, but headwinds might soon bog it down.

Via The Motley Fool

Roche's Muscular Atrophy Treatment Improves Motor Function In Pretreated Patients ↗

October 12, 2022

Via Benzinga

Does Biogen's Recent Win Make It a Must-Buy Stock? ↗

October 12, 2022

Will Biogen investors be let down again, or is this the real deal?

Via The Motley Fool

4 Biotech Stocks With Huge Incoming Catalysts ↗

October 12, 2022

All four of these drugmakers are expecting important FDA approval decisions over the next few months.

Via The Motley Fool

Biotech Stocks Well-Positioned For The Fourth Quarter ↗

October 12, 2022

The path of interest rates is clearer for 2022 and the FED is closer to a pause early next year as it calibrates its response from a hammer approach so far.

Via Talk Markets

Is This Stock a Buy After Soaring by 37%? ↗

October 06, 2022

Don't press the buy button too fast.

Via The Motley Fool

Despite Advancement, Benefits From Alzheimer's Drugs May Be Limited, Say Researchers ↗

October 10, 2022

Via Benzinga

These 7 Biotech Stocks Are Set to Boom in 2023 ↗

October 10, 2022

This article looks at seven biotech stocks that look like good options to move significantly higher in 2023

Via InvestorPlace

Eli Lilly Leads 5 Stocks To Watch In Bear Market ↗

October 08, 2022

Eli Lilly is holding up, while others crumbled Friday amid the market sell-off.

Via Investor's Business Daily

MarketBeat: Week in Review 10/3-10/7

October 08, 2022

The jobs report is fueling a sell-off to end the week with more volatility on tap for next week. Here are some of the most popular articles from this week.

Via MarketBeat

Topics Economy Electric Vehicles

Benzinga's Top Ratings Upgrades, Downgrades For October 7, 2022 ↗

October 07, 2022

Upgrades

Via Benzinga

One Of Eli Lilly's Most Anticipated Drugs Could Hit The Market Next Year ↗

October 06, 2022

The Street is closely watching Lilly's efforts in obesity and Alzheimer's.

Via Investor's Business Daily

3 Alzheimer Stocks to Buy as the Race for a Cure Heats Up

October 06, 2022

Here is a look at three names that buy-and-hold investors may want to consider as the race to find a cure for Alzheimer's disease accelerates

Via MarketBeat

Should You Sell Your FANGMAN Stocks? ↗

October 05, 2022

In addition to energy, investors have been fleeing to healthcare stocks for safety. And they have been selling the big tech names, especially the semiconductors.

Via Talk Markets

Hey Biogen Investors, Don’t Chase BIIB Stock! ↗

October 05, 2022

If BIIB stock already reflects Biogen's early-stage Alzheimer's disease study results, then the next move could easily be to the downside.

Via InvestorPlace

Will Investors Notice Exciting Sign On Biogen's Chart? ↗

October 05, 2022

If history is any guide, there may be good fortune ahead for shares of Biogen (NASDAQ:BIIB). A so-called "golden cross" has formed on its chart and, not surprisingly, this could be bullish for the...

Via Benzinga

2 Signals to Watch Before Buying SAVA Stock ↗

October 05, 2022

SAVA stock got ahead of itself in September, but if it continues to pull back, a solid entry point could emerge for this risky biotech play.

Via InvestorPlace

Peering Into Biogen's Recent Short Interest ↗

October 04, 2022

Biogen's (NASDAQ:BIIB) short percent of float has risen 9.52% since its last report. The company recently reported that it has 2.07 million shares sold short, which is 1.61% of all regular shares that...

Via Benzinga

Vyant Bio Inc. (NASDAQ: VYNT): Leading a New Biotech Move to Combat Diseases Affecting the Nervous System ↗

October 04, 2022

Biotechnology companies such as Biogen Inc. (NASDAQ: BIIB), Alector Inc.

Via Benzinga

Large Cap Biopharmaceuticals: Core Holdings For Your Portfolio ↗

October 03, 2022

Now that some clarity is apparent for drug pricing legislation you should have a few large-cap biopharmaceutical stocks in your portfolio.

Via Talk Markets

US Supreme Court Turns Away Biogen's Last Effort To Reinstate Tecfidera Patent ↗

October 03, 2022

The U.S. Supreme Court decided not to hear the case related to reinstating the patent of Biogen Inc's (NASDAQ: BIIB) blockbuster drug Tecfidera.

Via Benzinga

Biogen and Denali Therapeutics Announce Initiation of the Phase 3 LIGHTHOUSE Study in Parkinson’s Disease Associated with LRRK2 Pathogenic Mutations

October 03, 2022

From Denali Therapeutics Inc.

Via GlobeNewswire

Stock Market Falls, S&P 500 Hits Bear Lows; Biogen, Nike, Micron Are Key Movers: Weekly Review ↗

September 30, 2022

The major indexes fell, with the S&P 500 breaking below bear market lows.

Via Investor's Business Daily

Biogen Announced EMA Filing Acceptance of BIIB800, A Biosimilar Candidate Referencing RoACTEMRA® (tocilizumab)

September 30, 2022

From Biogen Inc.

Via GlobeNewswire

10 Health Care Stocks Whale Activity In Today's Session ↗

September 29, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Why NLS Pharmaceutics Shares Tumbled Over 66%; Here Are 68 Biggest Movers From Yesterday ↗

September 29, 2022

Gainers PepGen Inc. (NASDAQ: PEPG) jumped 110.2% to close at $10.93 after the company announced results from its Phase 1 healthy volunteer trial of PGN-EDO51 for Duchenne Muscular Dystrophy. The trial...

Via Benzinga

Netflix, Biogen And Other Big Gainers From Wednesday ↗

September 29, 2022

U.S. stocks closed higher with the Dow Jones surging more than 500 points on Wednesday. Here is the list of some big stocks recording gains in the previous session.

Via Benzinga

7 Growth Stocks to Buy to Tap Into a Hidden Bull Market ↗

September 28, 2022

It's become a bit easier for investors to find growth stocks to buy hidden amid the bear market.

Via InvestorPlace

These Stocks Are On The Radar After Biogen-Eisai's Surprising Alzheimer's Trial Win ↗

September 28, 2022

Via Benzinga

Here's How Much $100 Invested In Biogen 20 Years Ago Would Be Worth Today ↗

September 28, 2022

Biogen (NASDAQ:BIIB) has outperformed the market over the past 20 years by 2.9% on an annualized basis producing an average annual return of 10.93%. Currently, Biogen has a market capitalization of...

Via Benzinga

< Previous 1 2

...

30 31 32 33 34 35 36 37 38

...

56 57 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.